EKF.LSE EKF Diagnostics Holdings Plc

Healthcare Health Care Equipment & Supplies London Exchange
0.2340 GBX
Close of Nov 3, 2026
21.80 29.00
Market cap
GBX 100M
P/E
23.4x
P/B
1.43x
ROE
13.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is EKF.LSE undervalued?

Graham number
Price0.2340
Graham value0.1919
Premium21.9%

EKF.LSE trades 21.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EKF Diagnostics Holdings Plc fundamental analysis

No fundamental analysis for EKF Diagnostics Holdings Plc yet.

EKF Diagnostics Holdings Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EKF Diagnostics Holdings Plc

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such…

Full company profile